Literature DB >> 28043131

Frozen in Time: Kinetically Stabilized Amorphous Solid Dispersions of Nifedipine Stable after a Quarter Century of Storage.

Frank Theil1, Sankaran Anantharaman1, Samuel O Kyeremateng1, Holger van Lishaut1, Sebastian H Dreis-Kühne1, Jörg Rosenberg1, Markus Mägerlein1, Gerd H Woehrle1.   

Abstract

Kinetically stabilized amorphous solid dispersions are inherently metastable systems. Therefore, such systems are generally considered prone to recrystallization. In some cases, the formation of crystals will impact the bioavailability of the active pharmaceutical ingredient in these formulations. Recrystallization therefore may present a significant risk for patients as it potentially lowers the effective dose of the pharmaceutical formulation. This study indicates that such metastable formulations may indeed remain fully amorphous even after more than two decades of storage under ambient conditions. Different formulations of nifedipine stored for 25 years were compared with freshly prepared samples. A thorough physicochemical characterization including polarized light microscopy, differential scanning calorimetry, X-ray powder diffraction, and transmission Raman spectroscopy was undertaken. This in-depth characterization indicates no signs of recrystallization in the stored samples. The observations presented here prove that long-term stability of amorphous solid dispersions much beyond the typical shelf life for pharmaceutical formulations is indeed possible by kinetic stabilization alone. These findings implicate a reevaluation of the propensity to recrystallize for kinetically stabilized amorphous solid dispersions.

Entities:  

Keywords:  amorphous solid dispersion; crystallinity; long-term stability; nifedipine; physicochemical characterization; recrystallization

Mesh:

Substances:

Year:  2016        PMID: 28043131     DOI: 10.1021/acs.molpharmaceut.6b00783

Source DB:  PubMed          Journal:  Mol Pharm        ISSN: 1543-8384            Impact factor:   4.939


  10 in total

1.  Influence of Low-Molecular-Weight Excipients on the Phase Behavior of PVPVA64 Amorphous Solid Dispersions.

Authors:  Kristin Lehmkemper; Samuel O Kyeremateng; Matthias Degenhardt; Gabriele Sadowski
Journal:  Pharm Res       Date:  2018-01-05       Impact factor: 4.200

2.  Gelatin Nano-coating for Inhibiting Surface Crystallization of Amorphous Drugs.

Authors:  Rattavut Teerakapibal; Yue Gui; Lian Yu
Journal:  Pharm Res       Date:  2018-01-05       Impact factor: 4.200

3.  Stable amorphous solid dispersions of fenofibrate using hot melt extrusion technology: Effect of formulation and process parameters for a low glass transition temperature drug.

Authors:  Venkata Raman Kallakunta; Sandeep Sarabu; Suresh Bandari; Amol Batra; Vivian Bi; Thomas Durig; Michael A Repka
Journal:  J Drug Deliv Sci Technol       Date:  2019-11-18       Impact factor: 3.981

4.  β-Carotene solid dispersion prepared by hot-melt technology improves its solubility in water.

Authors:  Kenji Ishimoto; Shohei Miki; Akane Ohno; Yuta Nakamura; Shuichi Otani; Mikihiko Nakamura; Shinsaku Nakagawa
Journal:  J Food Sci Technol       Date:  2019-06-10       Impact factor: 2.701

5.  A Hot-Melt Extrusion Risk Assessment Classification System for Amorphous Solid Dispersion Formulation Development.

Authors:  Samuel O Kyeremateng; Kristin Voges; Stefanie Dohrn; Ekaterina Sobich; Ute Lander; Stefan Weber; David Gessner; Rachel C Evans; Matthias Degenhardt
Journal:  Pharmaceutics       Date:  2022-05-12       Impact factor: 6.525

6.  Dual mechanism of microenvironmental pH modulation and foam melt extrusion to enhance performance of HPMCAS based amorphous solid dispersion.

Authors:  Anh Q Vo; Xin Feng; Jiaxiang Zhang; Feng Zhang; Michael A Repka
Journal:  Int J Pharm       Date:  2018-08-21       Impact factor: 5.875

Review 7.  Melt extrusion with poorly soluble drugs - An integrated review.

Authors:  Michael A Repka; Suresh Bandari; Venkata Raman Kallakunta; Anh Q Vo; Haley McFall; Manjeet B Pimparade; Ajinkya M Bhagurkar
Journal:  Int J Pharm       Date:  2017-11-02       Impact factor: 5.875

8.  Use of Terahertz-Raman Spectroscopy to Determine Solubility of the Crystalline Active Pharmaceutical Ingredient in Polymeric Matrices during Hot Melt Extrusion.

Authors:  Ecaterina Bordos; Muhammad T Islam; Alastair J Florence; Gavin W Halbert; John Robertson
Journal:  Mol Pharm       Date:  2019-09-09       Impact factor: 4.939

9.  Hot-Melt Extruded Amorphous Solid Dispersion for Solubility, Stability, and Bioavailability Enhancement of Telmisartan.

Authors:  Bhupendra Raj Giri; Jaewook Kwon; Anh Q Vo; Ajinkya M Bhagurkar; Suresh Bandari; Dong Wuk Kim
Journal:  Pharmaceuticals (Basel)       Date:  2021-01-18

Review 10.  Co-Amorphous Drug Formulations in Numbers: Recent Advances in Co-Amorphous Drug Formulations with Focus on Co-Formability, Molar Ratio, Preparation Methods, Physical Stability, In Vitro and In Vivo Performance, and New Formulation Strategies.

Authors:  Jingwen Liu; Holger Grohganz; Korbinian Löbmann; Thomas Rades; Nele-Johanna Hempel
Journal:  Pharmaceutics       Date:  2021-03-15       Impact factor: 6.321

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.